The Metabolic Cost of Stress: A New Pathway for Cancer Progression
A study published in *Brain, Behavior, and Immunity* investigates the biological link between chronic stress from depression and the advancement of ovarian cancer. The research identifies a mechanism where stress-related metabolic dysfunction and the activation of a transcription factor called IRF1 lead to significant immune suppression within the tumor microenvironment. This work provides a concrete molecular pathway explaining how psychological factors can directly influence cancer biology and patient outcomes.
Why it might matter to you: For hepatology professionals, this research underscores the systemic impact of metabolic dysfunction, a core component of conditions like NAFLD and NASH. It highlights how metabolic disturbances, whether from liver disease or other sources like chronic stress, can have far-reaching consequences on immune function and disease progression. Understanding these interconnected pathways is crucial for a holistic view of patient care, where managing metabolic health extends beyond the liver to influence overall oncological and immunological risk.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
